Meta Pixel

News and Announcements

SUDA Business Development Update and AGM Presentation

  • Published November 17, 2015 4:12PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

17th November 2015

SUDA LTD (ASX: SUD), a leader in oro-mucosal drug delivery, today announces that it is on track with its business development goals to sign licensing deals in FY2015/16 and to secure philanthropic funding for a second Phase III study of ArTiMist™ in paediatric malaria.

In early November, the management team attended the BIO-Europe international partnering conference, which was held in Munich, Germany; and also the Northern Australian Investment Forum on tropical diseases, which took place in Darwin. These events provided excellent opportunities for the Company to further advance its business development activities.

SUDA’s business development team met with 41 companies at the BIO-Europe event, comprising 24 first-time meetings and 17 ongoing dialogues with prospective partners. The most advanced discussions are at the stage of financial negotiation and span several of the companies’ first-in-class oral sprays in various territories.

To read the full announcement, please click on the link below. 

To view the presentation, please click here.

Capital Insights
Where’s the beef? Blackstone just answered the AI question.

In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]

Company Updates
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation

For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]

Join over 45,000+ sophisticated investors

Join Now